Cheng Chang
-
- Beetle Biology and Toxicology Studies 3
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 3
-
- Chemokine receptors and signaling 6
-
- Acute Myeloid Leukemia Research 5
-
- Hematological disorders and diagnostics 4
-
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Neurological Disease Mechanisms and Treatments 3
- Co-authors
- Youqing ZhuLingsong ZhangYu‐Chin ChiuKaren J. FoliShiquan LiuJun LuoWenhui TaoXiaoyan Tang
- Journals
- Journal of Hazardous Materials (1 paper)Neuropsychopharmacology (1 paper)Journal of Ethnopharmacology (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Cheng Chang
33 papers receiving 477 citations
Peers
Comparison fields: 5 of 94
- Cancer Research 122
- Toxicology 16
- Emergency Medical Services 26
- Microbiology 22
- Molecular Biology 213
Countries citing papers authored by Cheng Chang
This map shows the geographic impact of Cheng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Chang more than expected).
Fields of papers citing papers by Cheng Chang
This network shows the impact of papers produced by Cheng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Chang. The network helps show where Cheng Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 16 | |
| 10 | 2021 | 81 | |
| 11 | 2021 | 52 | |
| 12 | 2019 | 12 | |
| 13 | 2015 | 22 | |
| 14 | 2014 | 17 | |
| 15 | [The inhibitory effect of matrine on the growth of human colorectal cancer HT29 cells: an experimental observation]. | 2014 | 2 |
| 16 | 2013 | 21 | |
| 17 | 2013 | 52 | |
| 18 | 2010 | 51 | |
| 19 | 2010 | 31 | |
| 20 | 1996 | 43 |
About Cheng Chang
Cheng Chang is a scholar working on Toxicology, Hematology and Cancer Research, having authored 37 papers that have together received 490 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (6 papers), Acute Myeloid Leukemia Research (5 papers), Hematological disorders and diagnostics (4 papers), Beetle Biology and Toxicology Studies (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Neurological Disease Mechanisms and Treatments (3 papers), RNA modifications and cancer (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (122 citations), Toxicology (16 citations) and Emergency Medical Services (26 citations). Cheng Chang has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Youqing Zhu, Lingsong Zhang, Yu‐Chin Chiu, Karen J. Foli, Shiquan Liu, Jun Luo, Wenhui Tao, Xiaoyan Tang, Wen Huang and Yuhan Wang. Their work appears in journals such as Journal of Hazardous Materials, Neuropsychopharmacology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.